Accessibility Menu
Precision Peptide logo

Precision Peptide

(OTC) PNGAF

Current Price$0.36
Market Cap$10.27M
Since IPO (2022)-85%
5 YearN/A
1 Year+5,117%
1 Month+7%

Precision Peptide Financials at a Glance

Market Cap

$10.27M

Revenue (TTM)

CA$92.77K

Net Income (TTM)

-CA$5.78M

EPS (TTM)

-$0.15

P/E Ratio

-2.41

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.36

Volume

27,837

Open

$0.34

Previous Close

$0.36

Daily Range

$0.34 - $0.36

52-Week Range

$0.01 - $0.50

Estimated Earnings Date

N/A

PNGAF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Precision Peptide

Industry

Food Products

CEO

Pratapvir Sandhu

Headquarters

Surrey, BC V3W 0H7, CA

PNGAF Financials

Key Financial Metrics (TTM)

Gross Margin

-49%

Operating Margin

-45%

Net Income Margin

-92%

Return on Equity

-2426%

Return on Capital

-2%

Return on Assets

-3%

Earnings Yield

-41.49%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$10.27M

Shares Outstanding

28.52M

Volume

27.84K

Avg. Volume

25.60K

Financials (TTM)

Gross Profit

-CA$69.16K

Operating Income

-CA$2.25M

EBITDA

-CA$2.16M

Operating Cash Flow

-CA$2.33M

Capital Expenditure

-CA$5.61

Free Cash Flow

-CA$2.33M

Cash & ST Invst.

CA$959.88K

Total Debt

CA$0.00

Precision Peptide Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

CA$43.06K

N/A

Gross Profit

-CA$739.78K

N/A

Gross Margin

-17.18%

N/A

Market Cap

$10.27M

N/A

Market Cap/Employee

$5.13M

N/A

Employees

2

N/A

Net Income

-CA$1.40M

-607.6%

EBITDA

-CA$1.44M

-628.6%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

CA$414.51K

+96.2%

Total Debt

CA$0.00

-100.0%

Accounts Receivable

CA$70.36K

+140.4%

Inventory

CA$61.96K

N/A

Long Term Debt

CA$0.00

N/A

Short Term Debt

CA$0.00

-100.0%

Return on Assets

-3.44%

N/A

Return on Invested Capital

-2.42%

N/A

Free Cash Flow

-CA$584.36K

-212.1%

Operating Cash Flow

-CA$584.35K

-212.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
AIXNAiXin Life International, Inc.
$0.32+0.00%
GLUCGlucose Health, Inc.
$0.45-13.51%
RELVReliv' International, Inc.
$2.25+0.00%
TOFBTofutti Brands Inc.
$0.64+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.59+0.04%
TQQQProShares Trust - ProShares UltraPro Qqq
$77.52+0.02%
SMCISuper Micro Computer
$30.46-0.05%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$40.04-0.02%

Questions About PNGAF

What is the current price of Precision Peptide?

Precision Peptide is trading at $0.36 per share.

What is the 52-week range for Precision Peptide?

Over the past 52 weeks, Precision Peptide has traded between $0.01 and $0.50.

How much debt does Precision Peptide have?

As of the most recent reporting period, Precision Peptide reported total debt of CA$0.00.

How much cash does Precision Peptide have on hand?

Precision Peptide reported CA$305.62K in cash and cash equivalents in its most recent financial results.

What is Precision Peptide’s dividend yield?

Precision Peptide does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.